Palvella Therapeutics, Inc. (PVLA) stock analysis

In our weekly check, Palvella Therapeutics, Inc. is graded D (A to F). Of 20 checks on debt, profit, cash flow and trend: 7 pass, warnings: 2, red flags: 11.

About Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PVLA.

What our checks show for PVLA

Red flags

Warning signs

Strengths

Similar companies

LKFT · IMNM · CLDX · MRVI · ALMR · PHVS

Questions

What grade does Palvella Therapeutics, Inc. (PVLA) have?

In our weekly check, Palvella Therapeutics, Inc. is graded D (A to F). Of 20 checks on debt, profit, cash flow and trend: 7 pass, warnings: 2, red flags: 11. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of PVLA stock?

This week's biggest flags for Palvella Therapeutics, Inc.: Weak interest cover, Gross margin falling, Weak EPS forecast. In total 13 of 20 checks show a warning or a red flag.

What does Palvella Therapeutics, Inc. do?

Palvella Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PVLA.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis